MAPT and Alzheimer disease: This speculation is further supported by a study conducted by Emrani et al. (2020), reporting that AD APOE4 carriers exhibit greater tau accumulation when compared to non-carriers, which was associated with greater memory impairments (Emrani et al., 2020).